Findings of a Pilot Study Brazilian dermatologists discovered in their recent study that collagen microneedling has caused beneficial skin changes with the goal of curing melasma.
Melasma is most common among women in the child-bearing ages of 25-50. The hyperpigmentation is usually caused by the abnormal production of melanin caused by changes in the hormones.
Ultraviolet radiation is also a contributing factor in worsening the visible effects.
The most classic melasma treatment involves addressing pigment deposits formed by hyperpigmentation. This prevents the production of more deposits as well as slowly minimizes the formed ones.
Dermatologists use different types of chemical peels and lasers to peel out the outermost layers of the skin with the most visible discolorations. This is paired with the application of topical sunscreens whose prophylactic properties lessens the damage caused by the sun. These methods have reported success and are now mixed with new technology in order to prevent further cases.
To understand melasma, it is vital to know that not only melanocytes are involved. This is the most common type of skin cell associated with the condition, but there are others as well. For instance, fibroblasts release substances that increase pigmentation response.
There are also other reported skin changes like membranes thinning out or skin structures being damaged. Microneedling is one process dermatologists use for many skin care treatments. It involves injecting collagen into the skin with the use of small needles. The inject collagen causes cellular growth that in turn repairs damaged tissues. Proliferation is good for curing or healing damage from radiation and pigmentation. Tying this effect with how melasma develops, scientist believe that the procedure is a good potential melasma treatment.
Is Collagen Microneedling Effective for Melasma?
A pilot study result was recently published by the BMC Journal of Dermatology. The study was conducted by Brazilian dermatologists and involved the use of microneedling procedures for recurring melasma treatment. The study included six patients with recurring melasma.
Microneedling was included in their daily treatment regimen and then all actions were recorded from the improvements of the symptoms to visible changes. Skin biopsies were also conducted to determine the beneficial effects of the procedure on a cellular level.
The study lasted for six months. After which, reports showed a significant improvement of the melasma conditions of all six patients. The patients unanimously reported satisfaction as well. Biopsy results showed that there were changes on a cellular level including a decrease of melanocyte activity and restoration of damaged cells. These results suggest that further studies should be conducted to support the integration of collagen microneedling in melasma treatment efforts. This is very fitting considering collagen’s reparative properties. This will greatly improve melasma technology and lead a new way for better skin care science.